In summary, our findings support the mechanism by which CYP2D6*10 (100C>T) polymorphisms confer susceptibility to HCC by altering CYP2D6 activity and TME, which contributes to hepatocarcinogenesis. Here, CYP2D6 is linked to hepatocellular carcinoma.